Showing results (1811-1820 of 2,130) with videos related to
Sort By:
Pageof 213
JAMA Dermatology|June 12, 2024
Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical TrialsShawn G Kwatra, Gil Yosipovitch, Brian Kim, et al.Bioengineering (Basel, Switzerland)|February 23, 2024
Ultrasound Flow Imaging Study on Rat Brain with Ultrasound and Light StimulationsJunhang Zhang, Chen Gong, Zihan Yang, et al.BMC Cancer|October 24, 2021
Implementing supportive exercise interventions in the colorectal cancer care pathway: a process evaluation of the PREPARE-ABC randomised controlled trialJamie Murdoch, Anna Varley, Jane McCulloch, et al.Family & Community Health|June 10, 2010
Mobilizing a region to redesign a local system of care: lessons from a community-based learning collaborativeDonna J Keyser, Harold Alan Pincus, Stephen B Thomas, et al.Investigative Ophthalmology & Visual Science|January 28, 2017
Vision Recovery and Connectivity by Fetal Retinal Sheet Transplantation in an Immunodeficient Retinal Degenerate Rat ModelMagdalene J Seiler, Robert E Lin, Bryce T McLelland, et al.Journal of the National Cancer Institute|March 8, 2007
Lung cancer risk among female textile workers exposed to endotoxinGeorge Astrakianakis, Noah S Seixas, Roberta Ray, et al.International Journal of Epidemiology|December 24, 2005
Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort studyChin-Kuo Chang, George Astrakianakis, David B Thomas, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 15, 2018
A new immunodeficient retinal dystrophic rat model for transplantation studies using human-derived cellsBiju B Thomas, Danhong Zhu, Tai-Chi Lin, et al.European Journal of Gastroenterology & Hepatology|September 24, 2025
Disease burden, diagnosis pathways and treatment patterns in patients with eosinophilic esophagitis: a real-world studyChristopher Ma, Ulrike von Arm, Frank Zerbib, et al.Bioorganic & Medicinal Chemistry|November 3, 2007
A new synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assayEmilie D Smith, N Ariane Vinson, Desong Zhong, et al.Pageof 213